By Professor (Keith) Chee Ooi

Preprints

Goddard TR; Carlson-Jones JA; Judith M; Ooi CY; Andrew T; Warner MS; John W; Evans IE; Hopkins E; Iredell JR; Jersmann HP; Whiteson KL; Bouras G; Doane MP; Falk NW; Green R; Grigson SR; Mallawaarachchi V; Martin B; Roach MJ; Ryan FJ; Tarasenko A; Papudeshi B; Drigo B; Giles SK; Harker CM; Hesse RD; Hodgson RJ; Hussnain A; Hutton A; Inglis LK; Keneally C; Kerr EN; Liddicoat C; Peddle SD; Watson CD; Yang Q; Decewicz P; Speck PG; Mitchell JG; Dinsdale EA; Edwards RA, 2026, Microbial Ecological Signatures Predict Pathogen Emergence and Multidrug Resistance in Cystic Fibrosis Airways up to a Year in Advance., http://dx.doi.org/10.64898/2025.12.28.25342520

Coffey MJ; van Dorst J; Pushpakumara BLDU; Halim J; Hudson J; Plush L; Christi K; Foster C; Carzino R; Zajakovski N; Appleton L; Cheney J; Wood J; Monaghan SJ; Rawlinson W; Day AS; Oliver M; Ranganathan S; Selvadurai H; Wainwright C; Thomas T; Jaffe A; Ooi CY, 2025, Probiotics and the EARly Life effects on intestinal bacteria and inflammation in children with Cystic Fibrosis (The “PEARL-CF” Study), http://dx.doi.org/10.64898/2025.12.04.25341620

Umashankar B; Capraro A; Vijayan A; Wong S; Nielsen B; Zhong L; Raftery M; Allan K; Ooi C; Sivam S; Visser S; Prentice B; Fawcett L; Kovacevic Z; Eliasson L; Faurholt-Jepsen D; Jaffe A; Shaw JAM; Vafaee F; Waters S, 2025, Serum Exosomal Multi-Omic Signatures Stratify Glucose Tolerance in Cystic Fibrosis and Reveal Partial Therapeutic Reprogramming by CFTR Modulators, http://dx.doi.org/10.1101/2025.07.07.25331056

Chan C; Coffey M; Murphy C; McKay I; Abdu J; Paida K; Tam R; Wrigley-Carr H; Prentice B; Owens L; Belessis Y; Chuang S; Jaffe A; van Dorst J; Ooi C, 2025, The Prevalence of pks⁺ E. coli in Cystic Fibrosis, http://dx.doi.org/10.20944/preprints202502.0874.v1

E TK; Wakefield C; Signorelli C; Day A; Vernon-Roberts A; Ooi C, 2023, Gastroenterology services for patients with Cystic Fibrosis across Australia and New Zealand: A multi-stakeholder assessment of patients’ and professionals’ perspectives, http://dx.doi.org/10.22541/au.168271385.50624670/v1

Wong S; Awatade N; Astore M; Allan K; Carnell M; Slapetova I; Chen P-C; Capraro A; Fawcett L; Whan R; Griffith R; Ooi C; Kuyucak S; Jaffe A; Waters S, 2021, In silicoand functional characterisation of an ultra-rareCFTRmutation identifies novel lasso motif interactions regulating channel gating, http://dx.doi.org/10.1101/2021.12.12.472297

Wong S; Awatade N; Astore M; Allan K; Carnell M; Slapetova I; Chen P-C; Setiadi J; Pandzic E; Fawcett L; Widger J; Whan R; Griffith R; Ooi C; Kuyucak S; Jaffe A; Waters S, 2021, Molecular dynamics and theratyping in airway and gut organoids reveal R352Q-CFTR conductance defect, http://dx.doi.org/10.1101/2021.08.11.456003

Perron JE; Coffey MJ; Lovell-Simons A; Dominguez L; King ME; Ooi CY, 2020, Resuscitating Cardiopulmonary Resuscitation Training in a Virtual Reality: Prospective Interventional Study (Preprint), http://dx.doi.org/10.2196/preprints.22920

Back to profile page